5/12
05:41 am
tgtx
TG Therapeutics, Inc. (
NASDAQ: TGTX) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Medium
Report
TG Therapeutics, Inc. (
NASDAQ: TGTX) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
4/19
10:23 am
tgtx
Rating for TGTX
Medium
Report
Rating for TGTX
4/19
10:23 am
tgtx
Rating for TGTX
Medium
Report
Rating for TGTX
4/19
10:23 am
tgtx
Rating for TGTX
Medium
Report
Rating for TGTX
2/26
09:54 am
tgtx
TG Therapeutics, Inc. (
NASDAQ: TGTX) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating.
Low
Report
TG Therapeutics, Inc. (
NASDAQ: TGTX) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating.